Jupiter Asset Management LTD Atara Biotherapeutics, Inc. Transaction History

Jupiter Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$4.69 - $9.84 $145,155 - $304,548	-30,950 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$14.7 - $19.89 $418,479 - $566,228	-28,468 Reduced 47.91%	30,950 $498,000
Q3 2021 Nov 10, 2021	SELL	$11.99 - $17.9 $501,122 - $748,130	-41,795 Reduced 41.29%	59,418 $1.06 Million
Q2 2021 Aug 10, 2021	BUY	$12.89 - $16.58 $1.3 Million - $1.68 Million	101,213 New	101,213 $1.57 Million

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.